HSBC Holdings
AXSM icon

HSBC Holdings’s Axsome Therapeutics AXSM Stock Holding History

HSBC Holdings’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Sell
55,800
-12,653
-18% -$2.74M 0.01% 882
2026
Q1 		$11.6M Buy
+68,453
New +$11.8M 0.01% 890
2025
Q4 		– Sell
-101,001
Closed -$12.3M – 2929
2025
Q3 		$12.3M Buy
101,001
+2,883
+3% +$325K 0.01% 858
2025
Q2 		$10.2M Buy
98,118
+14,546
+17% +$1.54M 0.01% 901
2025
Q1 		$9.74M Sell
83,572
-53,213
-39% -$6.06M 0.01% 905
2024
Q4 		$11.6M Sell
136,785
-279
-0.2% -$25.7K 0.01% 890
2024
Q3 		$12.3M Buy
137,064
+133,279
+3,521% +$11.6M 0.01% 862
2024
Q2 		$301K Sell
3,785
-1,051
-22% -$77.8K ﹤0.01% 2276
2024
Q1 		$386K Sell
4,836
-75,601
-94% -$6.35M ﹤0.01% 2248
2023
Q4 		$6.37M Sell
80,437
-68,375
-46% -$4.57M 0.01% 1065
2023
Q3 		$10.4M Buy
+148,812
New +$11.1M 0.01% 814
2021
Q1 		– Sell
-2,593
Closed -$211K – 2733
2020
Q4 		$211K Buy
+2,593
New +$194K ﹤0.01% 2787
2020
Q1 		– Sell
-2,401
Closed -$254K – 2698
2019
Q4 		$254K Buy
+2,401
New +$97K ﹤0.01% 2678

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

HSBC Holdings's AXSM Position: Q2 2026 in Review

HSBC Holdings reduced its Axsome Therapeutics (AXSM) stake by 18% in Q2 2026, selling an estimated $2.74M and leaving 55,800 shares worth $13.7M. The position accounts for 0.01% of the portfolio, ranked #882.

HSBC Holdings first reported a position in AXSM in Q4 2019 and has held it in 13 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • HSBC Holdings held 55,800 shares of Axsome Therapeutics worth $13.7M as of Q2 2026.
  • HSBC Holdings sold 12,653 Axsome Therapeutics shares in Q2 2026, an estimated $2.74M.
  • Axsome Therapeutics made up 0.01% of HSBC Holdings's portfolio in Q2 2026, its #882 holding.
  • HSBC Holdings first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 13 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.